Ferring Pharmaceuticals, Inc.
Elobixibat Colonic Motor Function Study
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Ferring Pharmaceuticals
- Registration Number
- NCT02392546
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy
- Conditions
- Bowel Preparation
- Interventions
- First Posted Date
- 2015-03-12
- Last Posted Date
- 2016-01-12
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 184
- Registration Number
- NCT02386449
- Locations
- 🇧🇷
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (there may be other sites in this country), Sao Paulo, Brazil
QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)
- First Posted Date
- 2015-02-23
- Last Posted Date
- 2018-07-05
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 117
- Registration Number
- NCT02368743
- Locations
- 🇫🇷
Gastro-Entérologie et Hépatologie - CHU Brabois (there may be other sites in this country), Vandoeuvre-les-Nancy, France
Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures
- First Posted Date
- 2015-02-23
- Last Posted Date
- 2017-06-02
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 23
- Registration Number
- NCT02368730
- Locations
- 🇩🇪
Charité - Universitätsmedizin Berlin (there may be other sites in this country), Berlin, Germany
An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
- First Posted Date
- 2015-02-23
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 281
- Registration Number
- NCT02368717
- Locations
- 🇨🇳
The 6th hospital affiliated to Zhongshan University (there may be other sites in this country), Guangzhou, China
A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment
- First Posted Date
- 2014-12-05
- Last Posted Date
- 2020-12-14
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 159
- Registration Number
- NCT02309671
- Locations
- 🇯🇵
Investigational site (there may be other sites in this country), Tokyo, Japan
Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
- First Posted Date
- 2014-10-10
- Last Posted Date
- 2022-05-20
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 150
- Registration Number
- NCT02261636
- Locations
- 🇳🇱
Gelre Ziekenhuizen (there may be other sites in this country), Zutphen, Netherlands
REgistry of MisOprostol 200 µg Vaginal dElivery System
- First Posted Date
- 2014-09-17
- Last Posted Date
- 2015-09-16
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 106
- Registration Number
- NCT02242214
- Locations
- 🇳🇱
Isala Klinieken (there may be other sites in this country), Zwolle, Netherlands
A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2016-06-23
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 204
- Registration Number
- NCT02239692
- Locations
- 🇩🇪
Gastroenterologie am Bayerischen Platz (there may be other sites in this country), Berlin, Germany
🇫🇷Ed Herriot Hopital (there may be other sites in this country), Lyon, France
🇳🇱Medisch Centrum Alkmaar (there may be other sites in this country), Alkmaar, Netherlands
Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.
- Conditions
- Advanced Prostate Cancer
- Interventions
- Drug: LHRH agonist (Leuprorelinacetat, Goserelinacetat, Buserelinacetat, Triptorelinacetat)
- First Posted Date
- 2014-09-09
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 461
- Registration Number
- NCT02234089
- Locations
- 🇩🇪
Investigational site (there may be other sites in this country), Rottweil, Germany